{"id":"NCT01620528","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-22","primaryCompletion":"2014-11-14","completion":"2015-09-28","firstPosted":"2012-06-15","resultsPosted":"2018-09-18","lastUpdate":"2018-09-18"},"enrollment":872,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Endometriosis"],"interventions":[{"type":"DRUG","name":"elagolix","otherNames":["ABT-620, elagolix sodium"]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Elagolix 150 mg QD","type":"EXPERIMENTAL"},{"label":"Elagolix 200 mg BID","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A randomized study evaluating the safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female participants.","primaryOutcome":{"measure":"Percentage of Responders at Month 3 Based on Daily Assessment of Dysmenorrhea (DYS)","timeFrame":"At Month 3 of the Treatment Period","effectByArm":[{"arm":"Placebo","deltaMin":19.6,"sd":null},{"arm":"Elagolix 150 mg QD","deltaMin":46.4,"sd":null},{"arm":"Elagolix 200 mg BID","deltaMin":75.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"},{"comp":"OG000 vs OG002","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28525302","34878624","34134684","33963686","33650259","33564263","33066973","32945631","32769633","32621325","31654294","31227284","30992150","30724096","29476499"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":374},"commonTop":["HOT FLUSH","HEADACHE","NAUSEA","URINARY TRACT INFECTION","FATIGUE"]}}